Bend Research installs its first commercial-scale spray dryer at its Oregon facility.
Bend Research, a division of Capsugel Dosage Form Solutions (DFS), has installed its first commercial-scale spray dryer at its R&D facility in Bend, OR. The new, high-capacity pharmaceutical spray dryer can be used for scale-up, quality-by-design (QbD), and the production of appropriate toxicology study supplies.
According to the company, this can provide for quicker development activities, as well as reduced cost and more flexible use of APIs. It also allows scale-up aspects of QbD to be integrated earlier into development for spray-dried products.
The installation is part of the company's multi-stage, $20 million expansion to enhance commercial manufacturing capabilities for spray-dried dispersions at its facilities in Oregon. The expansion is expected to be complete by mid-2015.
Source: Bend Research
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.